Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium.

The National Cancer Institute (NCI) Clinical Proteomic Tumor Analysis Consortium is applying the latest generation of proteomic technologies to genomically annotated tumors from The Cancer Genome Atlas (TCGA) program, a joint initiative of the NCI and the National Human Genome Research Institute. By providing a fully integrated accounting of DNA, RNA, and protein abnormalities in individual tumors, these datasets will illuminate the complex relationship between genomic abnormalities and cancer phenotypes, thus producing biologic insights as well as a wave of novel candidate biomarkers and therapeutic targets amenable to verification using targeted mass spectrometry methods.

[1]  S. Eschrich,et al.  Integrated Systems and Technologies Phosphoproteomics Identi fi es Driver Tyrosine Kinases in Sarcoma Cell Lines and Tumors , 2012 .

[2]  B. Domon,et al.  Targeted Proteomic Quantification on Quadrupole-Orbitrap Mass Spectrometer* , 2012, Molecular & Cellular Proteomics.

[3]  R. Aebersold,et al.  Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions , 2012, Nature Methods.

[4]  Bing Zhang,et al.  Integrative Omics Analysis Reveals the Importance and Scope of Translational Repression in microRNA-mediated Regulation , 2013, Molecular & Cellular Proteomics.

[5]  J. Yates,et al.  A model for random sampling and estimation of relative protein abundance in shotgun proteomics. , 2004, Analytical chemistry.

[6]  C. Ferrone,et al.  GeLC-MRM quantitation of mutant KRAS oncoprotein in complex biological samples. , 2012, Journal of proteome research.

[7]  C. Perou,et al.  The genomic landscape of breast cancer as a therapeutic roadmap. , 2013, Cancer discovery.

[8]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumors , 2012, Nature.

[9]  Steven J. M. Jones,et al.  Comprehensive molecular portraits of human breast tumours , 2013 .

[10]  David L. Tabb,et al.  Performance Metrics for Liquid Chromatography-Tandem Mass Spectrometry Systems in Proteomics Analyses* , 2009, Molecular & Cellular Proteomics.

[11]  N Leigh Anderson,et al.  High-throughput SISCAPA quantitation of peptides from human plasma digests by ultrafast, liquid chromatography-free mass spectrometry. , 2012, Journal of proteome research.

[12]  M. Mann,et al.  Ultra High Resolution Linear Ion Trap Orbitrap Mass Spectrometer (Orbitrap Elite) Facilitates Top Down LC MS/MS and Versatile Peptide Fragmentation Modes* , 2011, Molecular & Cellular Proteomics.

[13]  D. Lauffenburger,et al.  Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks , 2007, Proceedings of the National Academy of Sciences.

[14]  D R Mani,et al.  iTRAQ Labeling is Superior to mTRAQ for Quantitative Global Proteomics and Phosphoproteomics* , 2011, Molecular & Cellular Proteomics.

[15]  Christoph H Borchers,et al.  Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma , 2009, Nature Biotechnology.

[16]  S. Carr,et al.  Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry , 2013, Nature Methods.

[17]  Evan O. Paull,et al.  Molecular Pathways: Extracting Medical Knowledge from High-Throughput Genomic Data , 2013, Clinical Cancer Research.

[18]  Ronald J. Moore,et al.  Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum , 2012, Proceedings of the National Academy of Sciences.

[19]  Richard Z. Liu,et al.  Mass spectrometry mapping of epidermal growth factor receptor phosphorylation related to oncogenic mutations and tyrosine kinase inhibitor sensitivity. , 2011, Journal of proteome research.

[20]  Brendan MacLean,et al.  Bioinformatics Applications Note Gene Expression Skyline: an Open Source Document Editor for Creating and Analyzing Targeted Proteomics Experiments , 2022 .

[21]  Richard Z. Liu,et al.  Quantification of beta-catenin signaling components in colon cancer cell lines, tissue sections, and microdissected tumor cells using reaction monitoring mass spectrometry. , 2010, Journal of proteome research.